Angioplasty Balloons Market Size Analysis, Growth Trends & Forecast to 2034

Angioplasty Balloons Market Overview

The global Angioplasty Balloons market was valued at USD 2.96 billion in 2026 and is projected to reach USD 4.0 billion by 2034, expanding at a CAGR of 3.8% during the forecast period. The market is experiencing steady growth driven by the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and continuous advancements in interventional cardiology technologies.

Angioplasty balloons are essential medical devices used in minimally invasive procedures to open narrowed or blocked blood vessels, particularly arteries affected by plaque buildup. These devices are widely utilized in the treatment of Coronary Artery Disease and peripheral vascular conditions, helping restore normal blood flow and prevent severe complications such as heart attacks and strokes.

The increasing global burden of cardiovascular diseases, driven by aging populations, sedentary lifestyles, unhealthy diets, and rising incidence of conditions such as hypertension and diabetes, has significantly boosted the demand for angioplasty procedures. Balloon angioplasty is often preferred due to its minimally invasive nature, shorter recovery time, and lower procedural risks compared to traditional surgical interventions.

Technological advancements have led to the development of specialized balloon catheters, including drug-coated and cutting balloons, which improve treatment outcomes and reduce the risk of restenosis. As healthcare systems continue to focus on early intervention and efficient treatment of cardiovascular conditions, the angioplasty balloons market is expected to witness stable growth through 2034.

Angioplasty Balloons Market Drivers and Opportunities

Rising Prevalence of Cardiovascular Diseases Is Driving Market Growth

The increasing incidence of Coronary Artery Disease and other cardiovascular disorders is one of the primary drivers of the angioplasty balloon market. Cardiovascular diseases remain a leading cause of mortality worldwide, creating a significant demand for effective treatment solutions.

Factors such as unhealthy dietary habits, lack of physical activity, smoking, and stress are contributing to the growing prevalence of arterial blockages and heart-related conditions. As a result, there is a rising need for procedures that can restore blood flow and prevent life-threatening complications.

Angioplasty, supported by balloon catheters, is widely used as a first-line treatment for many cardiovascular conditions. The increasing number of patients requiring interventional procedures is directly contributing to the demand for angioplasty balloons.

Growing Adoption of Minimally Invasive Procedures Is Fueling Market Expansion

The shift toward minimally invasive medical procedures is significantly influencing the angioplasty balloons market. Patients and healthcare providers prefer minimally invasive techniques due to their advantages, including reduced hospital stays, faster recovery, and lower risk of complications.

Balloon angioplasty procedures are performed using catheter-based techniques that do not require large surgical incisions. This makes them highly suitable for elderly patients and individuals with multiple health conditions.

Additionally, advancements in imaging technologies and catheter design have improved the precision and safety of these procedures. The increasing availability of skilled healthcare professionals and specialized cardiac centers is further supporting the adoption of angioplasty procedures.

As the demand for efficient and less invasive treatment options continues to rise, the use of angioplasty balloons is expected to grow.

Technological Advancements and Development of Drug-Coated Balloons Present Significant Opportunities

Continuous innovation in angioplasty balloon technology is creating new growth opportunities in the market. Drug-coated balloons (DCBs) represent one of the most significant advancements, offering improved treatment outcomes by delivering therapeutic agents directly to the affected area.

These balloons help reduce the risk of restenosis by inhibiting cell proliferation, eliminating the need for permanent implants in certain cases. Cutting and scoring balloons are also gaining traction due to their ability to treat complex lesions with greater precision.

Manufacturers are focusing on developing balloons with enhanced flexibility, durability, and deliverability to improve procedural efficiency. Additionally, the integration of advanced materials and coatings is enhancing device performance.

Emerging markets present strong growth potential due to improving healthcare infrastructure, increasing awareness about cardiovascular diseases, and rising access to advanced treatment options.

Angioplasty Balloons Market Scope

Angioplasty Balloons Market Report Segmentation Analysis

The global angioplasty balloons market industry analysis is segmented by product type, by application, by end user, and by region.

The Normal Balloons Segment Is Expected to Dominate the Market During the Forecast Period

The normal balloons segment accounted for approximately 46.7% of the global market, making it the dominant category.

These balloons are widely used in standard angioplasty procedures due to their cost-effectiveness, ease of use, and broad applicability across various types of vascular conditions.

Coronary Angioplasty Segment Is Expected to Lead the Market by Application

The coronary angioplasty segment dominates the market as angioplasty balloons are extensively used in procedures targeting Coronary Artery Disease.

The high prevalence of coronary conditions and the increasing number of interventional procedures contribute to the strong demand in this segment.

The Hospitals Segment Is Expected to Dominate the End-User Market

Hospitals hold the largest share due to the availability of advanced medical infrastructure, skilled professionals, and specialized cardiac care units required for angioplasty procedures.

The following segments are part of an in-depth analysis of the global Angioplasty Balloons market:

Angioplasty Balloons Market Share Analysis By Region

North America is projected to hold the largest share of the global angioplasty balloons market over the forecast period.

North America accounted for approximately 40.3% of the global market in 2026, driven by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and early adoption of innovative medical technologies.

Asia Pacific is expected to register the highest CAGR during the forecast period due to increasing healthcare investments, rising patient population, and improving access to interventional procedures.

Angioplasty Balloons Market Competition Landscape Analysis

The market is highly competitive, with companies focusing on technological innovation, product differentiation, and strategic partnerships to strengthen their market position.

Global Angioplasty Balloons Market Recent Developments News:

∙ In March 2026 – New drug-coated balloon technologies were introduced to improve clinical outcomes.
∙ In November 2025 – Expansion of cardiovascular treatment centers increased procedure volumes.
∙ In August 2025 – Advances in catheter design enhanced procedural efficiency and safety.

The Global Angioplasty Balloons Market is dominated by a few large companies, such as

∙ Medtronic plc
∙ Boston Scientific Corporation
∙ Abbott Laboratories
∙ B. Braun Melsungen AG
∙ Terumo Corporation
∙ Cook Medical
∙ Cardinal Health
∙ BIOTRONIK SE & Co. KG
∙ Koninklijke Philips N.V.
∙ Lepu Medical Technology
∙ Others